Empirical versus progression-guided stereotactic radiosurgery for non-functional pituitary macroadenomas after subtotal resection.
Chien-Chen ChouHuai-Che YangChing-Jen ChenChung-Jung LinHsiu-Mei WuWen-Yuh ChungCheng-Ying ShiauWan-Yuo GuoDavid Hung-Chi PanPublished in: Journal of neuro-oncology (2019)
Empirical SRS offers higher rates of tumor control and progression-free survival compared to progression-guided SRS in patients with residual NFM after surgical resection. Rates of new hypopituitarism and cranial neuropathies were comparable between the two groups.
Keyphrases